Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2018 May 31;8:8469. doi: 10.1038/s41598-018-26727-4

Clinical and epidemiological features of Heart-Hand Syndrome: a hospital-based study in China

Yaobin Yin 1,✉,#, Jianguang Ji 2, Yan Borné 3, Yanqing Wang 1, Junhui Zhao 1, Shanlin Chen 1, Wen Tian 1,✉,#
PMCID: PMC5981449  PMID: 29855495

Abstract

Heart–hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co-occurrence of a congenital cardiac disease and an upper limb malformation. This study revealed the clinical and epidemiological features of HHS in China. The study was based on patients with congenital upper limb malformation treated in Beijing Ji Shui Tan hospital from October 1st, 2013 to October 1st, 2016. We reviewed the patients’ medical records and identified patients with abnormal ultrasonic cardiogram and/or electrocardiogram (ECG). A total of 1462 patients (910 male and 552 female) were identified to be treated for congenital upper limb malformation. Among them, 172 (11.8%) had abnormal ultrasonic cardiogram and/or ECG. Abnormal heart structure were discovered in 121 patients and 51 patients had abnormal ECG. The most common type of abnormal heart structure was tricuspid regurgitation (53/121, 43.8%), while the most common abnormal ECG was wave patterns (22/51, 43.1%). This hospital-based study suggests that the rate of congenital heart disease is high in patients treated for congenital upper extremity malformation in China. Surgeons and anesthetists should be aware of the comorbidity and preoperational examination of congenital heart diseases is highly needed to avoid complications during operation.

Introduction

Heart–hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co-occurrence of a congenital cardiac disease and a limb malformation1. The most common type of HHS is Holt–Oram syndrome (HOS) with an estimated incidence of 1/100 0002. The prevalence of HHS is low in Western countries, and an estimation of HHS rate in China is lacking until now. Because the mandatory policy of pre-marital medical check-up has stopped in China recently, an increased number of patients with congenital upper extremity malformation was noted as a consequence of the changed policy. We thus might expect that more HHS cases could be diagnosed soon in China35. Most congenital upper extremity malformations need surgical treatment. When congenital upper extremity malformation coexists with congenital heart disease, the complications might be higher during anesthesia and operation. It is thus highly necessary to explore the prevalence of HHS in patients with upper extremity malformation and to examine the strength to which it correlates with different upper limb malformation. The aims of this hospital-based study are (1) to estimate the prevalence of HHS among patients with a congenital limb malformation, (2) to analyze the characteristics and the clinical features of HHS in China.

Method

This study was approved by the Ethics Committee at Beijing Ji Shui Tan Hospital. All methods were carried out in accordance with relevant guidelines and regulations, and informed consent was obtained from all subjects.

All the patients treated for congenital upper extremity malformation in Hand Surgery Department of Beijing Ji Shui Tan Hospital between October 1st, 2013 and October 1st, 2016 were included in this study. We reviewed the medical records and checked the results of ultrasonic cardiogram and electrocardiogram (ECG). Patients with abnormal ultrasonic cardiogram and/or abnormal ECG were identified and met the criteria of clinical HHS. The clinical diagnostic criteria of HHS are congenital limb malformation combined with abnormal results of ultrasonic cardiogram or/and electrocardiogram. We further stratified upper extremity malformation according to Swanson upper extremity malformation classification (Supplement Table 1), and analyzed the rate of HHS for each type of upper extremity malformation, as well as the rate of various heart disease of HHS patients.

Statistics

Descriptive data were presented as number and percentage for categorical variables. P value was examined using chi square test. All the statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC, USA).

Data availability

The datasets generated during and/or analysed during the current study are not publicly available due to the including of privacy information but are available from the corresponding author on reasonable request.

Result

A total 1462 (910 male and 552 female) patients with congenital upper extremity malformations were identified and treated in Hand Surgery Department of Beijing Ji Shui Tan Hospital between October 1st, 2013 and October 1st, 2016. Among them, 172 (11.8%) patients had abnormal ultrasonic cardiogram and/or ECG, and met the clinical diagnostic criteria of HHS. The prevalence of HHS was not significantly different between male and female (Table 1). The most common malformations involved right side of upper limbs (47.3%), followed by left side involvement of upper limbs (29.1%) and bilateral involvement of upper limbs (23.6%). The prevalence of congenital cardiac disease was largely similar irrespective of right, left or bilateral involvement (Table 1).

Table 1.

Prevalence of congenital heart defect in patients with hand anomalies.

Characteristics No. of patients with hand anomalies (%) No. of patients with congenital heart defect (%) %* p value
Gender 0.86
Male 910 (62.2) 110 (64.0) 12.1
Female 552 (37.8) 62 (26.0) 11.2
Side of hand anomalies 0.51
Left 426 (29.1) 47 (27.3) 11.0
Right 691 (47.3) 80 (46.5) 11.6
Both hands 345 (23.6) 45 (26.2) 13.0
Overall 1462 172 11.8

*The percentage of No. of patients with congenital heart defect out of No. of patients with hand anomalies.

In Table 2 we present the prevalence of congenital cardiac disease stratified by different types of upper limb malformations according to Swanson classification of congenital upper limb malformation6. Type I (19.4%) and type II (11.5%) congenital upper limb malformations were more likely to present with congenital cardiac disease. Among them, 121 (8%) patients showed an abnormal heart structure as discovered by ultrasonic cardiogram and 51 (3%) patients had only abnormal result of ECG. Patients who had both abnormal ultrasonic cardiogram and abnormal ECG were classified in the group of heart structural abnormalities, and a total of 46 (3%) had both abnormal ultrasonic cardiogram and ECG. The most common type of abnormal heart structure was tricuspid regurgitation (53/121, 43.8%). The most common abnormal result of ECG was abnormal wave patterns (22/51, 43.1%). There was significant difference in terms of prevalence of congenital heart defect among different types of upper limb malformation (p = 0.01).

Table 2.

Prevalence of congenital heart defect stratified by different hand abnormality.

Hand abnormality No. patients Heart structural abnormality % Electrocardiographic abnormality % Total % p value
I Failure of formation of parts (arrest of development) 252 35 13.9 14 5.6 19.4
II Failure of differentiation (separation) of parts 278 18 6.5 14 5.0 11.5
III Duplication 765 57 7.5 19 2.5 9.9
IV Overgrowth 4 0 0.0 0 0.0 0.0
V Undergrowth 102 8 7.8 3 2.9 10.8
VI Congenital constriction band syndrom 61 3 4.9 1 1.6 6.6 0.01

The distribution of various congenital cardiac diseases among different type of upper limb malformations is shown in Table 3. There was significant difference for congenital cardiac disease among the three common types of upper limb malformations (p < 0.001).

Table 3.

Prevalence of various congenital heart defect in patients with hand anomalies.

Congenital heart defect I Retarded development % II Structural development disorde % III Duplication % p value
Atrial septal defect 12 4.76 0 0.00 11 1.44
Dextrocardia 1 0.40 0 0.00 1 0.13
Cor triatriatum 1 0.40 0 0.00 0 0.00
Tetralogy of fallot 0 0.00 0 0.00 1 0.13
Multiple valve regurgitation 2 0.79 1 0.36 5 0.65
Ventricular septal defect 1 0.40 1 0.36 0 0.00
Atrioventricular septal defect 1 0.40 0 0.00 0 0.00
Patent ductus arteriosus 1 0.40 1 0.36 1 0.13
Mitral regurgitation 1 0.40 0 0.00 2 0.26
Tricuspid regurgitation 9 3.57 10 3.60 30 3.92
Aortic valve regurgitation 3 1.19 2 0.72 3 0.39
Persistent left superior vena cava 1 0.40 2 0.72 0 0.00
Decreased left ventricular relaxation 2 0.79 1 0.36 3 0.39
Conduction block 6 2.38 3 1.08 4 0.52
Abnormal wave patterns 5 1.98 7 2.52 8 1.05
Premature beat 1 0.40 3 1.08 6 0.78
ECG axis deviation 2 0.79 0 0.00 1 0.13
Tachycardia 0 0.00 1 0.36 0 0.00 0.001

Discussion

In this hospital-based study in China, we reviewed the medical records of a total of 1462 patients with congenital upper extremity malformations, and found that around 12% of them presented with congenital heart disease, which met the clinical diagnosis criteria of HHS. The prevalence of HHS was largely similar irrespective of gender, and the side of congenital limb malformations. However, the rate of and the type of congenital heart diseases varied by different types of upper limb malformations.

HHS is well documented since first noted by Kato7 in 1924. It has been reported by many others subsequently8,9. Several types of HHS have been identified of which Holt-Oram Syndrome (HOS) is the best known, which was reported by Holt and Oram10 in 1960 based on a four-generation familial study. The results of a European epidemiological study showed that HOS is a very rare condition with an average prevalence of 0.7 per 100,000 births and a high regional variation (range between 0.3 and 2.4 per 100,000 births)11,12.

No epidemiological study was done for HHS so far. HHS is a broad category of diseases. The classification of HHS is shown in Supplementary Table 2. In our study, only 46 (27%) of HHS could be diagnosed as HOS according to the classification criteria listed in Supplementary Table 2. As suggested by McDermott12, a clinical diagnosis of HOS should include the presence of preaxial radial ray malformation of at least one upper limb along with a personal or family history of septation defects (ASD, VSD) and/or atrioventricular conduction disease. A genetic testing for TBX5, 22q11.2, microdeletion and Fanconi anaemia might be needed for final diagnosis11. However, it is unfortunately not possible in the current study to do genetic testing of patients with congenital upper limb malformation and to retrieve their family history of septation defects (ASD, VSD) and/or atrioventricular conduction disease, as all of these patients were already discharged from the hospital without possibility to contact them, which might explain part of the discrepancy for the relatively low rate of HOS in the current study as compared with the literatures. Most of them (73%) could not be classified according to current classification.

There was signification difference in term of the prevalence of congenital heart disease comorbid with different types of congenital upper limb malformations. According to Swanson classification of congenital upper limb malformations, the type I (Failure of formation of parts) and type II (Failure of differentiation) malformations were more likely to comorbid with congenital heart disease with a prevalence of 19.4% and 11.5%, respectively. Clinical doctors should be aware of these two types of congenital upper limb malformations. Pre-operational examination of the cardiovascular systems should be performed to avoid the risk of complications during operation. Thumb malformations, including radial polydactyly, radial ray deficiency, and thumb aplasia, were the most common malformations involved for HHS, accounted for 69.2% (119/172) of all HHS. This finding was in agreement with previous reports11,13. For patients with HOS, 14 patients involved left upper limbs and 20 patients involved right upper limbs. Bilateral involvement of upper limbs was noted in 12 patients, accounted for 26% of all HOS, which was lower than previous reports13. The prevalence of bilateral involvement was reported in 84% of patients with HOS, suggesting possible etiological difference between Chinese and Western population. In addition, it should be noted that most patients with HOS could be firstly treated in cardiac centers and therefore get lost in our study as we recruited only patients with congenital upper limb malformations, which might be the reason for the different rate and type of various congenital heart diseases as compared to the literatures.

The most common type of abnormal heart structure was tricuspid regurgitation (53/121, 44%), while the most common abnormal result of ECG was abnormal wave patterns (22/51, 43%). For HOS, the most common abnormal heart structure was atrial septal defect (ASD) and/or ventricular septal defect (VSD) (13/46 28%), which was lower than previous report. In the study reported by Lindley B wall13, ASD was the most common cardiovascular anomaly, presenting in 53% of HOS patients, and VSD was noted in 48% of HOS patients. The involvement of different abnormal heart structure in HHS or HOS suggests that possible etiological differences between Chinese and Western population. Despite similarities of the clinical presentations of various HHS, it remains unclear whether the hereditary of HHS arises from common or distinct genetic defects. It has been suggested that congenital heart diseases are caused by a limited number of shared genetic defects1417. However, some previous reports found that HHS are genetically heterogeneous with the possibility of arising from distinct disease genes1820. We speculated that genes underlying the development of various Chinese HHS might be different as the morphological and anatomic sites were inconsistent with previous reports. Further studies are highly needed to examine the underlying mechanisms and to explore whether the contribution of distinct disease genes was consistent in Chinese and Western population.

A few limitations should be kept in mind when we interpret the current findings. First, all the patients were identified from one hand clinic center, which might not be representative of the Chinese population. The second limitation was that this study was a retrospective epidemiological study and some individual information, such as family history of HHS which might be important to study HHS, was not available in the current study.

In summary, the comorbidity of congenital upper extremity malformations and congenital heart disease is relatively high in China, and the rate and type of various congenital heart disease differ as compared to previous reports, suggesting possible etiological difference between Chinese and Western population. Preoperational examination should cover the field of congenital heart disease to avoid complications during operation.

Electronic supplementary material

Supplementary tables (16.7KB, docx)

Author Contributions

Yaobin Yin had directly participated in the planning, execution and analysis of the study. Jianguang Ji and Yan Borné had participated in the planning and analysis of the study. Yanqing Wang had reviewed the patients’ medical record. Junhui Zhao, Shanlin Chen and Wen Tian had participated in the planning the study. Yaobin Yin and Wen Tian are co-corresponding authors.

Competing Interests

The authors declare no competing interests.

Footnotes

Yaobin Yin and Wen Tian contributed equally to this work.

Electronic supplementary material

Supplementary information accompanies this paper at 10.1038/s41598-018-26727-4.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Yaobin Yin, Email: yinyaobin586@163.com.

Wen Tian, Email: wentiansyz@hotmail.com.

References

  • 1.Basson CT, et al. Genetic heterogeneity of heart-hand syndromes. Circulation. 1995;91:1326–1329. doi: 10.1161/01.CIR.91.5.1326. [DOI] [PubMed] [Google Scholar]
  • 2.Elek C, Vitéz M, Czeizel E. Holt-Oram syndrome. Orv Hetil. 1991;132(73–74):77–78. [PubMed] [Google Scholar]
  • 3.Wei Qian LF, Huang Kuikui YY, Zhilan L. Birth defects and mortality trends during the inatal period in Lanzhou City. Chin J Reprod Heal. 2016;27:420–423. [Google Scholar]
  • 4.Zhong Fuzhen ZX, Yu Z. Analysis of birth defects supervision in obstetrical hospitals in Beijing Haidian District. Chinese Journal of Woman and Child Health Research. 2012;23:221–223. [Google Scholar]
  • 5.Study on the changing structure of disabled population caused by birth defects in China. Chinese Journal of Epidemiology31, 894–898 (2010). [PubMed]
  • 6.Swanson AB, Swanson GD, Tada K. A classification for congenital limb malformation. J Hand Surg Am. 1983;8:693–702. doi: 10.1016/S0363-5023(83)80249-4. [DOI] [PubMed] [Google Scholar]
  • 7.Kato K. Congenital absence of the radius with review of the literature and report of three cases. Journal of Bone and Joint Surgery. 1924;6:589–626. [Google Scholar]
  • 8.Zaragoza MV, Hakim SA, Hoang V, Elliott AM. Heart-hand syndrome IV: a second family with LMNA-related cardiomyopathy and brachydactyly. Clin Genet. 2017;91:499–500. doi: 10.1111/cge.12870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chryssostomidis G, et al. Diversity of congenital cardiac defects and skeletal deformities associated with the Holt-Oram syndrome. Int J Surg Case Rep. 2014;5:389–392. doi: 10.1016/j.ijscr.2014.04.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Holt M, Oram S. Familial heart disease with skeletal malformations. Br Heart J. 1960;22:236–242. doi: 10.1136/hrt.22.2.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Barisic I, et al. Holt Oram syndrome: a registry-based study in Europe. Orphanet J Rare Dis. 2014;9:156. doi: 10.1186/s13023-014-0156-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.McDermott DA, et al. TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res. 2005;58:981–986. doi: 10.1203/01.PDR.0000182593.95441.64. [DOI] [PubMed] [Google Scholar]
  • 13.Wall LB, et al. Defining Features of the Upper Extremity in Holt-Oram Syndrome. J Hand Surg Am. 2015;40:1764–1768. doi: 10.1016/j.jhsa.2015.06.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wilsdon A, Sifrim A, Hitz MP, Hurles M, Brook JD. Recent advances in congenital heart disease genomics. F1000Res. 2017;6:869. doi: 10.12688/f1000research.10113.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Edwards JJ, Gelb BD. Genetics of congenital heart disease. Curr Opin Cardiol. 2016;31:235–241. doi: 10.1097/HCO.0000000000000274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chaix MA, Andelfinger G, Khairy P. Genetic testing in congenital heart disease: A clinical approach. World J Cardiol. 2016;8:180–191. doi: 10.4330/wjc.v8.i2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Postma AV, Bezzina CR, Christoffels VM. Genetics of congenital heart disease: the contribution of the noncoding regulatory genome. J Hum Genet. 2016;61:13–19. doi: 10.1038/jhg.2015.98. [DOI] [PubMed] [Google Scholar]
  • 18.Steimle JD, Moskowitz IP. TBX5: A Key Regulator of Heart Development. Curr Top Dev Biol. 2017;122:195–221. doi: 10.1016/bs.ctdb.2016.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Jhang WK, Lee BH, Kim GH, Lee JO, Yoo HW. Clinical and molecular characterisation of Holt-Oram syndrome focusing on cardiac manifestations. Cardiol Young. 2015;25:1093–1098. doi: 10.1017/S1047951114001656. [DOI] [PubMed] [Google Scholar]
  • 20.Heinritz W, Shou L, Moschik A, Froster UG. The human TBX5 gene mutation database. Hum Mutat. 2005;26:397. doi: 10.1002/humu.9375. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary tables (16.7KB, docx)

Data Availability Statement

The datasets generated during and/or analysed during the current study are not publicly available due to the including of privacy information but are available from the corresponding author on reasonable request.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES